We've found
19,218 Lung Cancer
clinical trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma
Status: Enrolling,
Phase
Updated: 2/8/2016
Click here to add this to my saved trials
Oncology Clinical Trial
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
NY-ESO-1ᶜ²⁵⁹T for Advanced NSCLC
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Solid and Hematological Malignancies Clinical Trial
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Solid and Hematological Malignancies Clinical Trial
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Solid and Hematological Malignancies Clinical Trial
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 2/2/2016
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling,
Phase
II
Updated: 4/11/2018
Click here to add this to my saved trials
Recurrent Small Cell Lung Carcinoma Clinical Trial
Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Recurrent Small Cell Lung Carcinoma Clinical Trial
Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer With MET Exon 14 (METex14) Skipping Alterations or MET Amplification Clinical Trial
Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer With MET Exon 14 (METex14) Skipping Alterations or MET Amplification Clinical Trial
Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Neoplasm Clinical Trial
Veterans Affairs Lung Cancer Or Stereotactic Radiotherapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Non-small Cell Lung Cancer Clinical Trial
Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/13/2016
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Mesothelioma Clinical Trial
Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Mesothelioma Clinical Trial
Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Small Cell Lung Cancer (SCLC) Clinical Trial
Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small-Cell Lung Cancer Clinical Trial
Phase II Trial of Continuation Therapy in Advanced NSCLC
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small-Cell Lung Cancer Clinical Trial
Phase II Trial of Continuation Therapy in Advanced NSCLC
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
19,218 Lung Cancer
clinical trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/8/2016
Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma
Status: Enrolling,
Phase
Updated: 2/8/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
Updated: 12/31/1969
NY-ESO-1ᶜ²⁵⁹T for Advanced NSCLC
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Solid and Hematological Malignancies Clinical Trial
Updated: 12/31/1969
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Solid and Hematological Malignancies Clinical Trial
Updated: 12/31/1969
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Solid and Hematological Malignancies Clinical Trial
Updated: 12/31/1969
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
Updated: 3/24/2016
A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 3/24/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/2/2016
Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 2/2/2016
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 4/11/2018
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling,
Phase
II
Updated: 4/11/2018
Click here to add this to my saved trials
Recurrent Small Cell Lung Carcinoma Clinical Trial
Updated: 12/31/1969
Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Recurrent Small Cell Lung Carcinoma Clinical Trial
Updated: 12/31/1969
Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer With MET Exon 14 (METex14) Skipping Alterations or MET Amplification Clinical Trial
Updated: 12/31/1969
Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer With MET Exon 14 (METex14) Skipping Alterations or MET Amplification Clinical Trial
Updated: 12/31/1969
Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Updated: 12/31/1969
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Neoplasm Clinical Trial
Updated: 12/31/1969
Veterans Affairs Lung Cancer Or Stereotactic Radiotherapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Squamous Non-small Cell Lung Cancer Clinical Trial
Updated: 12/13/2016
Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/13/2016
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Mesothelioma Clinical Trial
Updated: 12/31/1969
Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Mesothelioma Clinical Trial
Updated: 12/31/1969
Ph 2/3 Study in Subjects With MPM w/Low ASS 1 Expression to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Small Cell Lung Cancer (SCLC) Clinical Trial
Updated: 12/31/1969
Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Lung Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small-Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Phase II Trial of Continuation Therapy in Advanced NSCLC
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small-Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Phase II Trial of Continuation Therapy in Advanced NSCLC
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials